PL376527A1 - Szczepionka zawierająca atenuowany żywy zarazek przeciwko zapaleniu płuc i opłucnej u świń - Google Patents

Szczepionka zawierająca atenuowany żywy zarazek przeciwko zapaleniu płuc i opłucnej u świń

Info

Publication number
PL376527A1
PL376527A1 PL376527A PL37652703A PL376527A1 PL 376527 A1 PL376527 A1 PL 376527A1 PL 376527 A PL376527 A PL 376527A PL 37652703 A PL37652703 A PL 37652703A PL 376527 A1 PL376527 A1 PL 376527A1
Authority
PL
Poland
Prior art keywords
live attenuated
vaccine against
attenuated vaccine
against porcine
porcine pleuropneumonia
Prior art date
Application number
PL376527A
Other languages
English (en)
Other versions
PL212312B1 (pl
Inventor
Ribas Jaume Pinol
Virgili Sergi Bru
Maso Enric Espuna
Murillo Enrique Querol
Original Assignee
Laboratorios Hipra, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hipra, S.A. filed Critical Laboratorios Hipra, S.A.
Publication of PL376527A1 publication Critical patent/PL376527A1/pl
Publication of PL212312B1 publication Critical patent/PL212312B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL376527A 2002-11-20 2003-11-17 Szczepionka zawierajaca atenuowany zywy zarazek przeciwko zapaleniu pluc i oplucnej u swin PL212312B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200202663A ES2233145B1 (es) 2002-11-20 2002-11-20 Vacuna viva atenuada contra la pleuroneumonia porcina.

Publications (2)

Publication Number Publication Date
PL376527A1 true PL376527A1 (pl) 2006-01-09
PL212312B1 PL212312B1 (pl) 2012-09-28

Family

ID=32319811

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376527A PL212312B1 (pl) 2002-11-20 2003-11-17 Szczepionka zawierajaca atenuowany zywy zarazek przeciwko zapaleniu pluc i oplucnej u swin

Country Status (17)

Country Link
US (1) US7722882B2 (pl)
EP (1) EP1575610B1 (pl)
JP (1) JP2006510612A (pl)
KR (1) KR101164045B1 (pl)
CN (1) CN100435845C (pl)
AT (1) ATE543511T1 (pl)
AU (1) AU2003288088A1 (pl)
BR (1) BRPI0316395B1 (pl)
CA (1) CA2505869C (pl)
DK (1) DK1575610T3 (pl)
ES (2) ES2233145B1 (pl)
MX (1) MXPA05005387A (pl)
PL (1) PL212312B1 (pl)
PT (1) PT1575610E (pl)
RU (1) RU2351360C2 (pl)
TW (1) TW200504209A (pl)
WO (1) WO2004045639A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100460503C (zh) * 2007-01-26 2009-02-11 华中农业大学 一种不含抗性标记的猪胸膜肺炎放线杆菌血清1型双基因缺失突变株的疫苗及应用
CN101265457B (zh) * 2007-07-20 2011-01-26 华中农业大学 区分疫苗免疫和野毒感染动物的猪胸膜肺炎放线杆菌血清7型双基因缺失突变株的疫苗及应用
TWI392737B (zh) * 2008-11-27 2013-04-11 Intervet Int Bv 產製ＲＴＸ毒素ＡｐｘＩ或ＡｐｘIII 之方法
TWI461529B (zh) * 2008-11-27 2014-11-21 Intervet Int Bv 產製ＲＴＸ毒素ＡｐｘＩ之方法
CN102058880B (zh) * 2010-10-13 2012-11-21 青岛易邦生物工程有限公司 猪传染性胸膜肺炎三价灭活疫苗的生产方法
ES2416154B1 (es) 2011-11-09 2015-04-01 Laboratorios Hipra, S.A. Cepa viva atenuada de Actinobacillus pleuropneumoniae
CN102517232B (zh) * 2011-12-15 2013-07-31 中国农业科学院哈尔滨兽医研究所 一种不含抗性标记的猪胸膜肺炎放线杆菌双基因缺失株、其构建方法及应用
CN102796679B (zh) * 2012-01-16 2014-09-24 四川农业大学 血清5型猪胸膜肺炎放线杆菌Apx I C/Apx II C双基因缺失疫苗候选株
KR101491795B1 (ko) * 2013-06-13 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 1번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101491793B1 (ko) 2013-09-10 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 12번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101705098B1 (ko) * 2014-05-29 2017-02-10 전북대학교산학협력단 약독화된 살모넬라 변이주를 포함하는 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
CN105664148B (zh) * 2016-01-25 2019-05-07 华南农业大学 一种基因工程亚单位混合疫苗及其制备方法和应用
KR102018707B1 (ko) * 2017-07-31 2019-09-06 주식회사 고려비엔피 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
EP3689373A1 (en) 2019-01-30 2020-08-05 IDT Biologika GmbH Inactivated apxia, apxiia and apxiiia toxins
GB202011902D0 (en) 2020-07-30 2020-09-16 Imperial College Innovations Ltd Antinobacillus pleuropneumoniae vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
AUPN631495A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(I)
ES2109189B1 (es) * 1996-03-14 1998-05-16 Iberica Cyanamid Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.

Also Published As

Publication number Publication date
TW200504209A (en) 2005-02-01
ES2233145A1 (es) 2005-06-01
CN1713921A (zh) 2005-12-28
PT1575610E (pt) 2012-03-16
EP1575610B1 (en) 2012-02-01
US7722882B2 (en) 2010-05-25
KR101164045B1 (ko) 2012-07-18
BRPI0316395B1 (pt) 2016-07-05
RU2005118761A (ru) 2006-02-27
RU2351360C2 (ru) 2009-04-10
JP2006510612A (ja) 2006-03-30
WO2004045639A1 (en) 2004-06-03
AU2003288088A1 (en) 2004-06-15
CA2505869A1 (en) 2004-06-03
US20060051371A1 (en) 2006-03-09
CA2505869C (en) 2012-03-20
MXPA05005387A (es) 2005-11-23
WO2004045639A8 (en) 2005-06-09
PL212312B1 (pl) 2012-09-28
KR20050062662A (ko) 2005-06-23
EP1575610A1 (en) 2005-09-21
ES2233145B1 (es) 2006-07-16
BR0316395A (pt) 2005-09-27
ES2381973T3 (es) 2012-06-04
ATE543511T1 (de) 2012-02-15
CN100435845C (zh) 2008-11-26
DK1575610T3 (da) 2012-05-14

Similar Documents

Publication Publication Date Title
PL376527A1 (pl) Szczepionka zawierająca atenuowany żywy zarazek przeciwko zapaleniu płuc i opłucnej u świń
MXPA04001982A (es) Factor ix modificado.
DK1263936T3 (da) andret stamme af den modificerede Vacciniavirus Ankara (MVA)
CY1115842T1 (el) Συμπληρωμενο ομv εμβολιο κατα μηνιγγιtiδοκοκκου
WO2021226436A8 (en) Optimized nucleotide sequences encoding sars-cov-2 antigens
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
EP1594536A4 (en) ADJUVANT INFLUENZA VACCINE
FR10C0042I1 (fr) Solubilisation de polysaccharides capsulaires
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
EP4670734A3 (en) Recombinant rsv antigens
MX2021014948A (es) Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
ATE419873T1 (de) Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs
EP1467771A4 (en) MYCOBACTERIAL VACCINE
MX2012004622A (es) Adyuvante para vacunas, vacunas que lo comprenden y usos.
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
WO2020227605A3 (en) Dna encoded il-36 gamma as an adjuvant
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
EA200400997A1 (ru) Способ, обеспечивающий профилактику туберкулёза у вич-положительных индивидов
WO2007028985A3 (en) Adjuvanted vaccine
AU6709500A (en) Trehalose producing cells as vaccines
MX2022004967A (es) Composiciones para el cuidado personal de ph bajo estables y metodos para las mismas.
HK1066027A1 (en) Bacillus anthracis strain